Psychotherapy, Meds Effective to Treat Depression in Patients With Heart Failure
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 19, 2024 -- For individuals with heart failure and depression, behavioral activation psychotherapy (BA) and antidepressant medication management (MEDS) reduce depressive symptoms, according to a study published online Jan. 17 in JAMA Network Open.
Waguih William IsHak, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues conducted a pragmatic randomized comparative effectiveness trial from 2018 to 2022 with one-year follow-up to compare the effectiveness of BA versus MEDS on patient-centered outcomes among patients with heart failure and depression. Overall, 416 patients were enrolled and randomly assigned to BA or MEDS (208 to each).
At baseline, the mean Patient Health Questionnaire 9-Item (PHQ-9) scores were 14.54 and 14.31 in the BA and MEDS groups, respectively. The researchers found that at three, six, and 12 months, both BA and MEDS recipients experienced nearly a 50 percent reduction in depressive symptoms (e.g., mean score at 12 months: 7.62 and 7.98 for BA and MEDS, respectively). There was no significant between-group difference in the primary outcome of PHQ-9 at six months (mean, 7.53 versus 8.09). Compared with MEDS recipients, BA recipients experienced small improvement in physical health-related quality of life at six months, had fewer emergency department visits at all time points, and spent fewer days hospitalized at all time points.
"Our findings demonstrate that both interventions are comparably effective in reducing depression for patients with heart failure, giving patients, caregivers, and health care practitioners the choice between BA and MEDS, thus improving patient-centered depression care in heart failure," the authors write.
One author disclosed ties to the publishing industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Teens May Experience Delays in Bipolar Progression After Major Depressive Disorder
FRIDAY, May 31, 2024 -- Adolescents may experience delayed bipolar disorder (BD) progression after major depressive disorder (MDD) diagnosis, according to a study published online...
Teen Smartphone Use Positively Tied to Mood
THURSDAY, May 30, 2024 -- Adolescent smartphone use is positively associated with mood, according to a study published online May 29 in PLOS ONE. Matt Minich, Ph.D., and...
Changes in Gender Identity Not Tied to Depressive Symptoms in Youth
WEDNESDAY, May 29, 2024 -- Changes in gender identity are not associated with changes in depressive symptoms over time among sexual and gender minority (SGM) youth, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.